SAN FRANCISCO, March 7, 2017 /PRNewswire/ -- Kindred
Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company
focused on saving and improving the lives of pets, is proud to
announce its partnership with the International Society of Equine
Locomotor Pathology (ISELP) by joining their team of Global
Sponsors starting in 2017. The partnership with ISELP is part of an
initiative by KindredBio to support the education of veterinarians
and veterinary students, and to promote the growth and advancement
of the equine industry. ISELP is an advanced education program for
equine veterinarians to learn the most advanced techniques in
diagnostics and treatments for the performance horse.
Kent Allen, DVM, Vice President
& Executive Director of ISELP said, "It is a great pleasure to
welcome KindredBio to the ISELP family of Global Sponsors. I am
thrilled that we have this opportunity. KindredBio fits into our
ISELP model because of their leading-edge technology and commitment
to excellence in equine healthcare. We look forward to many
productive years of collaboration and networking."
KindredBio looks forward to announcing its global sponsorship of
the ISELP Student Education Program starting in 2017, which will be
made to ISELP members attending the 3-Day meeting in Irving, Texas, March
7-11, 2017.
"The commitment to supporting continuing education of this
caliber for equine veterinarians and students is at the core of our
culture at KindredBio. We are honored to be partnered with ISELP,
an organization at the apex of equine education," said Denise Bevers, Co-Founder and Chief Operating
Officer of KindredBio.
About Kindred Biosciences
Kindred Biosciences is a development-stage biopharmaceutical
company focused on saving and improving the lives of pets.
Its mission is to bring to pets the same kinds of safe and
effective medicines that human family members enjoy. The
Company's strategy is to identify compounds and targets that have
already demonstrated safety and efficacy in humans and to develop
therapeutics based on these validated compounds and targets for
dogs, cats and horses. The Company has a deep pipeline of
novel drugs and biologics in development across many therapeutic
classes.
For more information or to download the corporate presentation,
visit www.KindredBio.com/LearnMore. Stay connected with KindredBio
on Facebook at www.Facebook.com/KindredBio.
About ISELP
"Continuing education of equine practitioners for a better
management of patients"
Formed in the United States, under
the direction of Dr. Jean-Marie
Denoix, The International Society of Equine Locomotor
Pathology (ISELP) will focus on the problem of lameness in the
equine athlete. The goal of ISELP is to provide contemporary
knowledge and techniques in the continually evolving field of
equine locomotor analysis to better prepare the equine clinician to
understand and manage lameness conditions in the equine
athlete. Founded in 2006, ISELP is rapidly growing and
currently has members on all five continents.
Contact
Russell Radefeld
KindredBio
russell.radefeld@kindredbio.com
(650) 701-7904
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/kindred-biosciences-announces-global-sponsorship-of-international-society-of-equine-locomotor-pathology-300418162.html
SOURCE Kindred Biosciences, Inc.